Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates
Open Access
- 1 May 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 47 (5) , 521-526
- https://doi.org/10.1093/jac/47.5.521
Abstract
Three methods were compared for the susceptibility testing of yeast isolates to fluconazole and amphotericin B: two fagar diffusion methods (Etest and a tablet diffusion test) and the National Committee for Clinical Laboratory Standards (NCCLS) broth microdilution method. Given as MIC50s (range), fluconazole endpoints were: for the 24 h broth microdilution test, 0.25 mg/L (0.06–32 mg/L); for the Etest, 0.38 mg/L (0.064–24 mg/L); and for the NCCLS broth microdilution test, 2 mg/L (0.06–≥64 mg/L). With breakpoints of 16 mg/L for resistant, the Etest and the 24 h microdilution test classified the isolates in agreement with the classification obtained by the NCCLS method. Results obtained by Etest were in closer NCCLS method than those obtained with the tablet test. Amphotericin B endpoints were lower for the 24 h microdilution and Etests than MICs obtained by the NCCLS broth microdilution method. Reproducibility was high for all tests; however, disadvantages of both diffusion tests were microcolonies in the inhibition zone and dependence on stringent standardization of inoculum.Keywords
This publication has 2 references indexed in Scilit:
- The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH DependentAntimicrobial Agents and Chemotherapy, 1999
- Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolatesAntimicrobial Agents and Chemotherapy, 1995